Morning Seminar April 24, 2007

J Clin Oncol. 2007 Apr 1;25(10):1190-5.
Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
Knight KR, Kraemer DF, Winter C, Neuwelt EA.

Morning Seminar April 19, 2007

J Clin Oncol. 2005 Aug 20;23(24):5675-87.
Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ.

Morning Seminar April 17, 2007

ASH 2006, part III

Morning Seminar April 12, 2007

Pediatr Blood Cancer. 2007 Jan 24; [Epub ahead of print]
Positron emission tomography/computed tomography with (18)fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.

Clin Nucl Med. 2006 Jul;31(7):394-7.
Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study.
Peng F, Rabkin G, Muzik O.

Morning Seminar April 10, 2007

J Clin Oncol. 2006 Dec 20;24(36):5725-34.
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma.
Coughlin CM, Fleming MD, Carroll RG, Pawel BR, Hogarty MD, Shan X, Vance BA, Cohen JN, Jairaj S, Lord EM, Wexler MH, Danet-Desnoyers GA, Pinkus JL, Pinkus GS, Maris JM, Grupp SA, Vonderheide RH.